| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Research Equipment Center and 3Department of Pharmacology, School of Medicine, Kagawa University, Kagawa; and 2Department of Applied Pharmacology and Therapeutics, Osaka City University Medical School, Osaka, Japan
Submitted 6 May 2005 ; accepted in final form 12 October 2005
Recently, a new member of the calcitonin gene-related peptide (CGRP) family, adrenomedullin 2 (AM2) or intermedin (IMD), was identified. AM2/IMD has been shown to have a vasodilator effect in mice and rats and an effect on urine formation in rats. In the present study, we investigated the effects of intravenously infused rat AM2 (rAM2) on blood pressure (BP), heart rate (HR), renal sympathetic nerve activity (RSNA), and renal blood flow (RBF) in conscious unrestrained rats relative to the effects of rat adrenomedullin (rAM) and proadrenomedullin NH2-terminal 20 peptide (rPAMP). Intravenous infusion of rAM2 (5 nmol/kg) significantly decreased BP and increased HR, RSNA, and RBF. These hypotensive and sympathoexcitatory effects diminished after 20 min, and HR returned to control levels 30 min after cessation of the infusion. In contrast, a significant increase in RBF was still evident 60 min after cessation of the peptide infusion. The duration of BP, HR, and RSNA responses was longer with rAM (5 nmol/kg) than with rAM2 infusion, whereas the increases in RBF induced by rAM2 and rAM were similar in their amplitude and duration. Infusion of rPAMP (200 nmol/kg) increased HR and RSNA but had no effect on RBF. Baroreceptor denervation suppressed, but did not diminish, the increases in HR and RSNA to rAM2. These findings indicate that the physiological roles of rAM2 and rAM are similar and that rAM2 also has a long-lasting vasodilator action on the renal vascular bed.
hemodynamics; sympathetic outflow; vasodilation
This article has been cited by other articles:
|
|
 |
|
  U. Pfeil, M. Aslam, R. Paddenberg, K. Quanz, C. L. Chang, J.-I. Park, B. Gries, A. Rafiq, P. Faulhammer, A. Goldenberg, et al. Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L837 - L845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Grossini, C. Molinari, D. A. S. G. Mary, F. Uberti, P. P. Caimmi, and G. Vacca Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and {beta}-adrenoreceptor-mediated nitric oxide release J Appl Physiol, October 1, 2009; 107(4): 1037 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Smith Jr., L. Gao, G. Bledsoe, L. Chao, and J. Chao Intermedin is a new angiogenic growth factor Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H1040 - H1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ogoshi, S. Nobata, and Y. Takei Potent osmoregulatory actions of homologous adrenomedullins administered peripherally and centrally in eels Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R2075 - R2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hagiwara, G. Bledsoe, Z.-R. Yang, R. S. Smith Jr., L. Chao, and J. Chao Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1735 - F1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nobata, M. Ogoshi, and Y. Takei Potent cardiovascular actions of homologous adrenomedullins in eels Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1544 - R1553. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
